The world’s largest clinical trial to
investigate whether aspirin is able
to prevent cancer has commenced
in the UK involving around 11,000
people who have had early bowel,
breast, prostate, stomach and
oesophageal cancer, according to
BBC News.
The study is funded by the charity
Cancer Research UK and the NIHR -
the research arm of the NHS.
Different daily doses of aspirin will
be compared against placebo over
a five-year study period.
Side effects will also be evaluated,
with researchers warning that the
drug is not suitable for everyone.The above article was sent to subscribers in Pharmacy Daily's issue from 27 Oct 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Oct 15
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.